AIM
AIM ImmunoTech
13 hedge funds and large institutions have $1.01M invested in AIM ImmunoTech in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$620K | |
| 2 | +$7K | |
| 3 | +$4.25K | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4K |
Top Sellers
| 1 | -$45.7K | |
| 2 | -$11K | |
| 3 | -$8K | |
| 4 |
Bank of New York Mellon
New York
|
-$4K |
| 5 |
VF
Virtu Financial
New York
|
-$1.43K |